Annual ROE
-215.13%
-104.46%-94.39%
June 30, 2024
Summary
- As of February 8, 2025, ANEB annual return on equity is -215.13%, with the most recent change of -104.46% (-94.39%) on June 30, 2024.
- During the last 3 years, ANEB annual ROE has fallen by -73.84% (-52.26%).
- ANEB annual ROE is now -374.90% below its all-time high of -45.30%, reached on June 30, 2022.
Performance
ANEB ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-184.40%
-45.48%-32.74%
September 30, 2024
Summary
- As of February 8, 2025, ANEB quarterly return on equity is -184.40%, with the most recent change of -45.48% (-32.74%) on September 30, 2024.
- Over the past year, ANEB quarterly ROE has dropped by -61.43% (-49.96%).
- ANEB quarterly ROE is now -326.65% below its all-time high of 81.36%, reached on December 31, 2020.
Performance
ANEB Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
ANEB ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -94.4% | -50.0% |
| 3 y3 years | -52.3% | -50.0% |
| 5 y5 years | - | -50.0% |
ANEB ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -374.9% | at low | -379.8% | +27.5% |
| 5 y | 5-year | -374.9% | at low | -326.6% | +77.1% |
| alltime | all time | -374.9% | at low | -326.6% | +77.1% |
Anebulo Pharmaceuticals ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -184.40%(+32.7%) |
| Jun 2024 | -215.13%(+94.4%) | -138.92%(+13.0%) |
| Mar 2024 | - | -122.97%(+12.4%) |
| Dec 2023 | - | -109.40%(+11.7%) |
| Sep 2023 | - | -97.92%(+21.4%) |
| Jun 2023 | -110.67% | -80.67%(+9.3%) |
| Mar 2023 | - | -73.81%(+16.0%) |
| Dec 2022 | - | -63.64%(+41.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2022 | - | -44.88%(+16.8%) |
| Jun 2022 | -45.30%(-67.9%) | -38.43%(-77.9%) |
| Mar 2022 | - | -173.76%(-31.7%) |
| Dec 2021 | - | -254.37%(-37.2%) |
| Sep 2021 | - | -405.13%(-49.7%) |
| Jun 2021 | -141.29% | -806.22%(-3688.0%) |
| Mar 2021 | - | 22.47%(-72.4%) |
| Dec 2020 | - | 81.36% |
FAQ
- What is Anebulo Pharmaceuticals annual return on equity?
- What is the all time high annual ROE for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals annual ROE year-on-year change?
- What is Anebulo Pharmaceuticals quarterly return on equity?
- What is the all time high quarterly ROE for Anebulo Pharmaceuticals?
- What is Anebulo Pharmaceuticals quarterly ROE year-on-year change?
What is Anebulo Pharmaceuticals annual return on equity?
The current annual ROE of ANEB is -215.13%
What is the all time high annual ROE for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high annual return on equity is -45.30%
What is Anebulo Pharmaceuticals annual ROE year-on-year change?
Over the past year, ANEB annual return on equity has changed by -104.46% (-94.39%)
What is Anebulo Pharmaceuticals quarterly return on equity?
The current quarterly ROE of ANEB is -184.40%
What is the all time high quarterly ROE for Anebulo Pharmaceuticals?
Anebulo Pharmaceuticals all-time high quarterly return on equity is 81.36%
What is Anebulo Pharmaceuticals quarterly ROE year-on-year change?
Over the past year, ANEB quarterly return on equity has changed by -61.43% (-49.96%)